Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8906880 Nucleoside phosphoramidate prodrugs
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 23 Oct, 2024
"update inverses"
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12121529 Nucleoside phosphoramidate prodrugs
0
Edits on 11 Sep, 2024
"update inverses"
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
0
Edits on 13 Jun, 2024
"update inverses"
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
0
Edits on 8 May, 2024
"update inverses"
Golden AI
edited on 8 May, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11975016 2′-substituted-N
0
Edits on 27 Sep, 2023
"Add patent inventor(s)"
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox
(
+4
properties)
Infobox
Patent Inventor Names
Dhanapalan Nagarathnam
0
Jinfa Du
0
Michael Joseph Sofia
0
Peiyuan Wang
0
Edits on 26 Jul, 2023
"update inverses"
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11707480 Highly active compounds against COVID-19
0
"update inverses"
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11707479 Combination formulation of two antiviral compounds
0
Edits on 5 Jul, 2023
"update inverses"
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11690860 Treatment of HCV infected patients with cirrhosis
0
Edits on 24 May, 2023
"Remove leading 0 from patent number"
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox
(
+1
/
-1
properties)
US Patent 08906880 Nucleoside phosphoramidate prodrugs
US Patent 8906880 Nucleoside phosphoramidate prodrugs
Infobox
Patent Number
08906880
0
Patent Number
8906880
0
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=08906880
0
Edits on 23 Apr, 2023
"Entity importer update"
Golden AI
edited on 23 Apr, 2023
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
08906880
0
Date of Patent
December 9, 2014
0
Patent Application Number
14255833
0
Date Filed
April 17, 2014
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=08906880
0
Patent Primary Examiner
Patrick Lewis
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08906880
Edits on 28 Dec, 2021
"Created via: Entity Importer"
Golden AI
created this topic on 28 Dec, 2021
Edits made to:
Infobox
(
+7
properties)
US Patent 08906880 Nucleoside phosphoramidate prodrugs
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
08906880
Date of patent
December 9, 2014
Patent application number
14255833
Date Filed
April 17, 2014
Patent primary examiner
Patrick Lewis
Find more entities like US Patent 8906880 Nucleoside phosphoramidate prodrugs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE